0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vascular Endothelial Growth Factor B Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-12C13921
Home | Market Reports | Health| Pharmacy
Global Vascular Endothelial Growth Factor B Market Research Report 2023
BUY CHAPTERS

Global Vascular Endothelial Growth Factor B Market Research Report 2025

Code: QYRE-Auto-12C13921
Report
September 2025
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vascular Endothelial Growth Factor B Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Vascular Endothelial Growth Factor B Market

Vascular Endothelial Growth Factor B Market

The global market for Vascular Endothelial Growth Factor B was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vascular Endothelial Growth Factor B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vascular Endothelial Growth Factor B.
The Vascular Endothelial Growth Factor B market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vascular Endothelial Growth Factor B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vascular Endothelial Growth Factor B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vascular Endothelial Growth Factor B Market Report

Report Metric Details
Report Name Vascular Endothelial Growth Factor B Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alteogen Inc, CSL Ltd, Eli Lilly and Company, Formycon AG, Regeneron Pharmaceuticals Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vascular Endothelial Growth Factor B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vascular Endothelial Growth Factor B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Vascular Endothelial Growth Factor B Market report?

Ans: The main players in the Vascular Endothelial Growth Factor B Market are Alteogen Inc, CSL Ltd, Eli Lilly and Company, Formycon AG, Regeneron Pharmaceuticals Inc

What are the Application segmentation covered in the Vascular Endothelial Growth Factor B Market report?

Ans: The Applications covered in the Vascular Endothelial Growth Factor B Market report are Rectal Cancer, Retinal Vein Occlusion, Diabetic Nephropathy, Others

What are the Type segmentation covered in the Vascular Endothelial Growth Factor B Market report?

Ans: The Types covered in the Vascular Endothelial Growth Factor B Market report are Aflibercept, Aflibercept Biosimilar, CSL-346, Others

Recommended Reports

Vascular Devices

Angiogenesis & Growth

Vascular Implants & Stents

1 Vascular Endothelial Growth Factor B Market Overview
1.1 Product Definition
1.2 Vascular Endothelial Growth Factor B by Type
1.2.1 Global Vascular Endothelial Growth Factor B Market Value Comparison by Type (2024 VS 2031)
1.2.2 Aflibercept
1.2.3 Aflibercept Biosimilar
1.2.4 CSL-346
1.2.5 Others
1.3 Vascular Endothelial Growth Factor B by Application
1.3.1 Global Vascular Endothelial Growth Factor B Market Value by Application (2024 VS 2031)
1.3.2 Rectal Cancer
1.3.3 Retinal Vein Occlusion
1.3.4 Diabetic Nephropathy
1.3.5 Others
1.4 Global Vascular Endothelial Growth Factor B Market Size Estimates and Forecasts
1.4.1 Global Vascular Endothelial Growth Factor B Revenue 2020-2031
1.4.2 Global Vascular Endothelial Growth Factor B Sales 2020-2031
1.4.3 Global Vascular Endothelial Growth Factor B Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vascular Endothelial Growth Factor B Market Competition by Manufacturers
2.1 Global Vascular Endothelial Growth Factor B Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vascular Endothelial Growth Factor B Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vascular Endothelial Growth Factor B Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vascular Endothelial Growth Factor B, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vascular Endothelial Growth Factor B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vascular Endothelial Growth Factor B, Product Type & Application
2.7 Global Key Manufacturers of Vascular Endothelial Growth Factor B, Date of Enter into This Industry
2.8 Global Vascular Endothelial Growth Factor B Market Competitive Situation and Trends
2.8.1 Global Vascular Endothelial Growth Factor B Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vascular Endothelial Growth Factor B Players Market Share by Revenue
2.8.3 Global Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vascular Endothelial Growth Factor B Market Scenario by Region
3.1 Global Vascular Endothelial Growth Factor B Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vascular Endothelial Growth Factor B Sales by Region: 2020-2031
3.2.1 Global Vascular Endothelial Growth Factor B Sales by Region: 2020-2025
3.2.2 Global Vascular Endothelial Growth Factor B Sales by Region: 2026-2031
3.3 Global Vascular Endothelial Growth Factor B Revenue by Region: 2020-2031
3.3.1 Global Vascular Endothelial Growth Factor B Revenue by Region: 2020-2025
3.3.2 Global Vascular Endothelial Growth Factor B Revenue by Region: 2026-2031
3.4 North America Vascular Endothelial Growth Factor B Market Facts & Figures by Country
3.4.1 North America Vascular Endothelial Growth Factor B Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vascular Endothelial Growth Factor B Sales by Country (2020-2031)
3.4.3 North America Vascular Endothelial Growth Factor B Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vascular Endothelial Growth Factor B Market Facts & Figures by Country
3.5.1 Europe Vascular Endothelial Growth Factor B Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vascular Endothelial Growth Factor B Sales by Country (2020-2031)
3.5.3 Europe Vascular Endothelial Growth Factor B Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vascular Endothelial Growth Factor B Market Facts & Figures by Region
3.6.1 Asia Pacific Vascular Endothelial Growth Factor B Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vascular Endothelial Growth Factor B Sales by Region (2020-2031)
3.6.3 Asia Pacific Vascular Endothelial Growth Factor B Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vascular Endothelial Growth Factor B Market Facts & Figures by Country
3.7.1 Latin America Vascular Endothelial Growth Factor B Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vascular Endothelial Growth Factor B Sales by Country (2020-2031)
3.7.3 Latin America Vascular Endothelial Growth Factor B Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vascular Endothelial Growth Factor B Market Facts & Figures by Country
3.8.1 Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vascular Endothelial Growth Factor B Sales by Type (2020-2031)
4.1.1 Global Vascular Endothelial Growth Factor B Sales by Type (2020-2025)
4.1.2 Global Vascular Endothelial Growth Factor B Sales by Type (2026-2031)
4.1.3 Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2031)
4.2 Global Vascular Endothelial Growth Factor B Revenue by Type (2020-2031)
4.2.1 Global Vascular Endothelial Growth Factor B Revenue by Type (2020-2025)
4.2.2 Global Vascular Endothelial Growth Factor B Revenue by Type (2026-2031)
4.2.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2020-2031)
4.3 Global Vascular Endothelial Growth Factor B Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vascular Endothelial Growth Factor B Sales by Application (2020-2031)
5.1.1 Global Vascular Endothelial Growth Factor B Sales by Application (2020-2025)
5.1.2 Global Vascular Endothelial Growth Factor B Sales by Application (2026-2031)
5.1.3 Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2031)
5.2 Global Vascular Endothelial Growth Factor B Revenue by Application (2020-2031)
5.2.1 Global Vascular Endothelial Growth Factor B Revenue by Application (2020-2025)
5.2.2 Global Vascular Endothelial Growth Factor B Revenue by Application (2026-2031)
5.2.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2020-2031)
5.3 Global Vascular Endothelial Growth Factor B Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Alteogen Inc
6.1.1 Alteogen Inc Company Information
6.1.2 Alteogen Inc Description and Business Overview
6.1.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio
6.1.5 Alteogen Inc Recent Developments/Updates
6.2 CSL Ltd
6.2.1 CSL Ltd Company Information
6.2.2 CSL Ltd Description and Business Overview
6.2.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio
6.2.5 CSL Ltd Recent Developments/Updates
6.3 Eli Lilly and Company
6.3.1 Eli Lilly and Company Company Information
6.3.2 Eli Lilly and Company Description and Business Overview
6.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio
6.3.5 Eli Lilly and Company Recent Developments/Updates
6.4 Formycon AG
6.4.1 Formycon AG Company Information
6.4.2 Formycon AG Description and Business Overview
6.4.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Formycon AG Vascular Endothelial Growth Factor B Product Portfolio
6.4.5 Formycon AG Recent Developments/Updates
6.5 Regeneron Pharmaceuticals Inc
6.5.1 Regeneron Pharmaceuticals Inc Company Information
6.5.2 Regeneron Pharmaceuticals Inc Description and Business Overview
6.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio
6.5.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vascular Endothelial Growth Factor B Industry Chain Analysis
7.2 Vascular Endothelial Growth Factor B Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vascular Endothelial Growth Factor B Production Mode & Process Analysis
7.4 Vascular Endothelial Growth Factor B Sales and Marketing
7.4.1 Vascular Endothelial Growth Factor B Sales Channels
7.4.2 Vascular Endothelial Growth Factor B Distributors
7.5 Vascular Endothelial Growth Factor B Customer Analysis
8 Vascular Endothelial Growth Factor B Market Dynamics
8.1 Vascular Endothelial Growth Factor B Industry Trends
8.2 Vascular Endothelial Growth Factor B Market Drivers
8.3 Vascular Endothelial Growth Factor B Market Challenges
8.4 Vascular Endothelial Growth Factor B Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Vascular Endothelial Growth Factor B Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vascular Endothelial Growth Factor B Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vascular Endothelial Growth Factor B Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vascular Endothelial Growth Factor B Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Vascular Endothelial Growth Factor B Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vascular Endothelial Growth Factor B Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vascular Endothelial Growth Factor B Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vascular Endothelial Growth Factor B Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vascular Endothelial Growth Factor B, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vascular Endothelial Growth Factor B, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vascular Endothelial Growth Factor B, Product Type & Application
 Table 12. Global Key Manufacturers of Vascular Endothelial Growth Factor B, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vascular Endothelial Growth Factor B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor B as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vascular Endothelial Growth Factor B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vascular Endothelial Growth Factor B Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2020-2025)
 Table 19. Global Vascular Endothelial Growth Factor B Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2026-2031)
 Table 21. Global Vascular Endothelial Growth Factor B Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2020-2025)
 Table 23. Global Vascular Endothelial Growth Factor B Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2026-2031)
 Table 25. North America Vascular Endothelial Growth Factor B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Vascular Endothelial Growth Factor B Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Vascular Endothelial Growth Factor B Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vascular Endothelial Growth Factor B Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vascular Endothelial Growth Factor B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Vascular Endothelial Growth Factor B Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Vascular Endothelial Growth Factor B Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vascular Endothelial Growth Factor B Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vascular Endothelial Growth Factor B Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Vascular Endothelial Growth Factor B Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vascular Endothelial Growth Factor B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Vascular Endothelial Growth Factor B Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Vascular Endothelial Growth Factor B Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vascular Endothelial Growth Factor B Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vascular Endothelial Growth Factor B Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Vascular Endothelial Growth Factor B Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
 Table 53. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2026-2031)
 Table 54. Global Vascular Endothelial Growth Factor B Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vascular Endothelial Growth Factor B Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2020-2025)
 Table 57. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2026-2031)
 Table 58. Global Vascular Endothelial Growth Factor B Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Vascular Endothelial Growth Factor B Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Vascular Endothelial Growth Factor B Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Vascular Endothelial Growth Factor B Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2025)
 Table 63. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2026-2031)
 Table 64. Global Vascular Endothelial Growth Factor B Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vascular Endothelial Growth Factor B Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2020-2025)
 Table 67. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2026-2031)
 Table 68. Global Vascular Endothelial Growth Factor B Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Vascular Endothelial Growth Factor B Price (USD/Pcs) by Application (2026-2031)
 Table 70. Alteogen Inc Company Information
 Table 71. Alteogen Inc Description and Business Overview
 Table 72. Alteogen Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Alteogen Inc Vascular Endothelial Growth Factor B Product
 Table 74. Alteogen Inc Recent Developments/Updates
 Table 75. CSL Ltd Company Information
 Table 76. CSL Ltd Description and Business Overview
 Table 77. CSL Ltd Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. CSL Ltd Vascular Endothelial Growth Factor B Product
 Table 79. CSL Ltd Recent Developments/Updates
 Table 80. Eli Lilly and Company Company Information
 Table 81. Eli Lilly and Company Description and Business Overview
 Table 82. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Eli Lilly and Company Vascular Endothelial Growth Factor B Product
 Table 84. Eli Lilly and Company Recent Developments/Updates
 Table 85. Formycon AG Company Information
 Table 86. Formycon AG Description and Business Overview
 Table 87. Formycon AG Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Formycon AG Vascular Endothelial Growth Factor B Product
 Table 89. Formycon AG Recent Developments/Updates
 Table 90. Regeneron Pharmaceuticals Inc Company Information
 Table 91. Regeneron Pharmaceuticals Inc Description and Business Overview
 Table 92. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product
 Table 94. Regeneron Pharmaceuticals Inc Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Vascular Endothelial Growth Factor B Distributors List
 Table 98. Vascular Endothelial Growth Factor B Customers List
 Table 99. Vascular Endothelial Growth Factor B Market Trends
 Table 100. Vascular Endothelial Growth Factor B Market Drivers
 Table 101. Vascular Endothelial Growth Factor B Market Challenges
 Table 102. Vascular Endothelial Growth Factor B Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vascular Endothelial Growth Factor B
 Figure 2. Global Vascular Endothelial Growth Factor B Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vascular Endothelial Growth Factor B Market Share by Type: 2024 & 2031
 Figure 4. Aflibercept Product Picture
 Figure 5. Aflibercept Biosimilar Product Picture
 Figure 6. CSL-346 Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Vascular Endothelial Growth Factor B Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Vascular Endothelial Growth Factor B Market Share by Application: 2024 & 2031
 Figure 10. Rectal Cancer
 Figure 11. Retinal Vein Occlusion
 Figure 12. Diabetic Nephropathy
 Figure 13. Others
 Figure 14. Global Vascular Endothelial Growth Factor B Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Vascular Endothelial Growth Factor B Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Vascular Endothelial Growth Factor B Sales (2020-2031) & (K Pcs)
 Figure 17. Global Vascular Endothelial Growth Factor B Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Vascular Endothelial Growth Factor B Report Years Considered
 Figure 19. Vascular Endothelial Growth Factor B Sales Share by Manufacturers in 2024
 Figure 20. Global Vascular Endothelial Growth Factor B Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Vascular Endothelial Growth Factor B Players: Market Share by Revenue in Vascular Endothelial Growth Factor B in 2024
 Figure 22. Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Vascular Endothelial Growth Factor B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Vascular Endothelial Growth Factor B Sales Market Share by Country (2020-2031)
 Figure 25. North America Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country (2020-2031)
 Figure 29. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Vascular Endothelial Growth Factor B Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Vascular Endothelial Growth Factor B Revenue Market Share by Region (2020-2031)
 Figure 37. China Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Vascular Endothelial Growth Factor B Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Vascular Endothelial Growth Factor B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Vascular Endothelial Growth Factor B by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Vascular Endothelial Growth Factor B by Type (2020-2031)
 Figure 59. Global Vascular Endothelial Growth Factor B Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Vascular Endothelial Growth Factor B by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Vascular Endothelial Growth Factor B by Application (2020-2031)
 Figure 62. Global Vascular Endothelial Growth Factor B Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Vascular Endothelial Growth Factor B Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart